| Revised Total Coliform Rule | Health-Based | N/A | N/A | Sep 28, 2025 | Active | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Sep 28, 2025 | Active | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2025 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Jul 9, 2025 | Active | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Jul 9, 2025 | Active | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Jul 8, 2025 | Active | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Jul 8, 2025 | Active | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Public Notice | Monitoring | N/A | N/A | Jul 1, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 1, 2025 | Active | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Active | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 8, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 8, 2025 | Active | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Feb 25, 2025 | Active | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Feb 25, 2025 | Active | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Atrazine | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | Cardiovascular system or reproductive problems |
| Atrazine | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | Cardiovascular system or reproductive problems |
| Atrazine | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | Cardiovascular system or reproductive problems |
| Atrazine | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | Cardiovascular system or reproductive problems |
| Atrazine | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | Cardiovascular system or reproductive problems |
| Endrin | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Endrin | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Endrin | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Endrin | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Endrin | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| BHC-GAMMA | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| BHC-GAMMA | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| BHC-GAMMA | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| BHC-GAMMA | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| BHC-GAMMA | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| OXAMYL | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| OXAMYL | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| OXAMYL | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| OXAMYL | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| OXAMYL | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Simazine | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Simazine | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Simazine | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Simazine | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Simazine | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Di(2-ethylhexyl) phthalate | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Di(2-ethylhexyl) phthalate | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Di(2-ethylhexyl) phthalate | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Di(2-ethylhexyl) phthalate | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Di(2-ethylhexyl) phthalate | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Dinoseb | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Dinoseb | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Dinoseb | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Dinoseb | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Dinoseb | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Hexachlorocyclopentadiene | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Hexachlorocyclopentadiene | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Hexachlorocyclopentadiene | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Hexachlorocyclopentadiene | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Hexachlorocyclopentadiene | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| LASSO | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| LASSO | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| LASSO | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| LASSO | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| LASSO | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Heptachlor | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Heptachlor | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Heptachlor | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Heptachlor | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Heptachlor | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Heptachlor epoxide | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Heptachlor epoxide | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Heptachlor epoxide | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Heptachlor epoxide | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Heptachlor epoxide | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| 2,4,5-TP | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| 2,4,5-TP | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| 2,4,5-TP | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| 2,4,5-TP | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| 2,4,5-TP | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| HEXACHLOROBENZENE | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| HEXACHLOROBENZENE | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| HEXACHLOROBENZENE | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| HEXACHLOROBENZENE | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| HEXACHLOROBENZENE | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Benzo(a)pyrene | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Benzo(a)pyrene | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Benzo(a)pyrene | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Benzo(a)pyrene | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Benzo(a)pyrene | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Pentachlorophenol | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Pentachlorophenol | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Pentachlorophenol | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Pentachlorophenol | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Pentachlorophenol | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Total Polychlorinated Biphenyls (PCB) | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Total Polychlorinated Biphenyls (PCB) | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Total Polychlorinated Biphenyls (PCB) | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Total Polychlorinated Biphenyls (PCB) | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Total Polychlorinated Biphenyls (PCB) | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Chlordane | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Chlordane | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Chlordane | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Chlordane | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Chlordane | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Di(2-ethylhexyl) adipate | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Di(2-ethylhexyl) adipate | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Di(2-ethylhexyl) adipate | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Di(2-ethylhexyl) adipate | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Di(2-ethylhexyl) adipate | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Toxaphene | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| 1,2-DIBROMO-3-CHLOROPROPANE | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| 1,2-DIBROMO-3-CHLOROPROPANE | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| 1,2-DIBROMO-3-CHLOROPROPANE | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| 2,4-D | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| 2,4-D | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| 2,4-D | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| 2,4-D | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| 2,4-D | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Picloram | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Picloram | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Picloram | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| 1,2-DIBROMO-3-CHLOROPROPANE | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Picloram | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| ETHYLENE DIBROMIDE | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| ETHYLENE DIBROMIDE | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| ETHYLENE DIBROMIDE | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| ETHYLENE DIBROMIDE | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| ETHYLENE DIBROMIDE | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Toxaphene | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Toxaphene | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Toxaphene | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| 1,2-DIBROMO-3-CHLOROPROPANE | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Picloram | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Methoxychlor | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Methoxychlor | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Methoxychlor | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Methoxychlor | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Methoxychlor | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Carbofuran | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Carbofuran | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Carbofuran | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Carbofuran | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Carbofuran | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Toxaphene | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Dec 18, 2024 | Active | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Dec 18, 2024 | Active | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| LEAD AND COPPER RULE REVISIONS | Health-Based | N/A | N/A | Oct 16, 2024 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Health-Based | N/A | N/A | Oct 16, 2024 | Active | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2023 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Active | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 27, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 27, 2023 | Active | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Nickel | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Nickel | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Nickel | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Nickel | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Nickel | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Thallium, Total | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Thallium, Total | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Thallium, Total | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Thallium, Total | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Thallium, Total | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| CYANIDE | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Nerve damage or thyroid problems |
| CYANIDE | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Nerve damage or thyroid problems |
| CYANIDE | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Nerve damage or thyroid problems |
| CYANIDE | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Nerve damage or thyroid problems |
| CYANIDE | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Nerve damage or thyroid problems |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Cadmium | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Kidney damage |
| Cadmium | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Kidney damage |
| Cadmium | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Kidney damage |
| Cadmium | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Kidney damage |
| Cadmium | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Kidney damage |
| Chromium | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Allergic dermatitis |
| Chromium | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Allergic dermatitis |
| Chromium | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Allergic dermatitis |
| Chromium | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Allergic dermatitis |
| Chromium | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Allergic dermatitis |
| Mercury | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Kidney damage |
| Mercury | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Kidney damage |
| Mercury | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Kidney damage |
| Mercury | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Kidney damage |
| Mercury | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Kidney damage |
| Selenium | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Selenium | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Selenium | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Selenium | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Selenium | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Antimony, Total | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Antimony, Total | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Antimony, Total | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Antimony, Total | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Beryllium, Total | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Beryllium, Total | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Beryllium, Total | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Beryllium, Total | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Beryllium, Total | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Antimony, Total | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Fluoride | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Barium | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Increase in blood pressure |
| Barium | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Increase in blood pressure |
| Barium | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Increase in blood pressure |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Barium | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Increase in blood pressure |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Barium | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Increase in blood pressure |